In the STEP 1 trial, adults with obesity who received semaglutide 2.4 mg weekly achieved a mean weight loss of 14.9% of initial body weight over 68 weeks, compared to 2.4% with placebo
Over 40% of GLP-1 users experience nausea at some point, and switching between medications can trigger a new round of GI adjustment even in people who had fully adapted to their previous medication
Most compounding pharmacies will reship at no additional cost for genuine temperature excursions, especially during summer months when the problem is well known
Its often the result of reduced calorie intake, changes in your metabolism, or dehydration
With competitive pricing, insurance assistance, and the convenience of virtual consultations, accessing this transformative treatment has never been easier